SavedAdd your journal

Journals / Eurasian Journal of Veterinary Sciences / 2010 / Cilt: 26 - Sayı: 1

Deneysel olarak civa klorür ile böbrek hasarı oluşturulan farelerde sülfametaksazolün farmakokinetiğinin değerlendirilmesi

Influence of mercury chloride-renal failure on pharmacokinetics of sulphamethoxazole after oral administration in mice

Levent ALTINTAS
Mert PEKCAN
Ender YARSAN
Gulay CİFTCİ
Arif ALTINTAS
Dinc ESSİZ
Ishraga G. IBRAHİM
Pages
21–24
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Significant findings (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Yarsan E, Altintas A, Essiz D, Altintas L, Pekcan M, Ciftci G, Ibrahim IG.
📊
Key Findings & Data:Eurasian J Vet Sci, 2010, 26, 1, 21-24 Aim: The effects of renal failure on the pharmacokinetics of sulphamethoxazole were investigated after oral administration of 100 mg/kg of the drug using a mice model of mercury chloride-induced renal failure.
💡
Conclusion & Impact:Results: Significant findings (p
🔬Design:Modeling & Simulation
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Yarsan E, Altintas A, Essiz D, Altintas L, Pekcan M, Ciftci G, Ibrahim IG. Influence of mercury chloride-renal failure on pharmacokinetics of sulphamethoxazole after oral administration in mice. Eurasian J Vet Sci, 2010, 26, 1, 21-24 Aim: The effects of renal failure on the pharmacokinetics of sulphamethoxazole were investigated after oral administration of 100 mg/kg of the drug using a mice model of mercury chloride-induced renal failure. Materials and Methods: Mercury chloride was given to mice at the doses of 3 and 6 mg/kg. Plasma sulphamethoxazole concentrations were measured by spectrophotometer. Plasma concentration-time data were fitted to a two-compartment open model. Results: Significant findings (p

Özet

Yarsan E, Altıntaş A, Eşsiz D, Altıntaş L, Pekcan M, Çiftci G, İbrahim IG. Farelerde Cıva Klorür ile Oluşturulan Böbrek Hasarının Oral Yolla Uygulanan Sülfametaksazolün Farmakokinetiği Üzerine Etkisi. Eurasian J Vet Sci, 2010, 26, 1, 21-24 Amaç: Bu çalışmada, deneysel olarak cıva klorür ile böbrek hasarı oluşturulmuş farelerde 100 mg/kg dozda oral yolla uygulanan sülfametoksazolün farmakokinetiği değerlendirildi. Gereç ve Yöntem: Cıva klorür farelere 3 ve 6 mg/kg dozlarında verildi. Plazma sülfametaksazol konsantrasyonları spektrofotometre ile ölçüldü. Plazma konsantrasyon-zaman verileri dikkate alındığında ilacın 2 kompartmanlı açık modele uygun olduğu görüldü. Bulgular: Böbrek hasarı ile ilişkili olarak sülfametoksazolün emilim (AUC and $t_{1/2a}$) ve eliminasyon ($t_{1/2beta}$ and MRT) fazlarında önemli bulgular (p

🔖

Cite This Article

ALTINTAS, L., PEKCAN, M., YARSAN, E., CİFTCİ, G., ALTINTAS, A., ESSİZ, D., IBRAHİM, I. G. (2022). Deneysel olarak civa klorür ile böbrek hasarı oluşturulan farelerde sülfametaksazolün farmakokinetiğinin değerlendirilmesi. Eurasian Journal of Veterinary Sciences, Cilt: 26 - Sayı: 1, 21–24. https://ajindex.com/articles/510188

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Altıntaş A, Şahal M, Çelik S, Duru O, Ocal N, 2001. Serum ve idrar proteinlerinin elektroforetik analizi ve veteriner hekimlikteki önemi. Turk J Vet Anim Sci, 25, 93- 104. Bae SK, Kwon JW, Kim WB, Lee I, Lee MG, 2006. Effects of acute renal failure on the pharmacokinetics of DA- 7867, a new oxazolidinone, in rats. Biopharm Drug Dispos, 27, 29-37.
  2. Barnett M, Bushby SRM, 1970. Trimethoprim and the sulphonamides. Vet Rec, 87, 39-42.
  3. Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D’Amico G, 1997. Characterization of proteinuria in primary glomerulonephritides. SDS-PAGE pattern: clinical significance and prognostic value of low molecular weight (“tubular”) proteins. Am J Kidney Dis, 29, 27- 35. Bevil RF, 1988. Sulfonamides. In: Veterinary Pharmacology and Therapeutics, Ed; Booth NH, Sixth edition, Iowa State University, Ames, USA, pp: 785-795. Bishop Y, 2005. The Veterinary Formulary. Sixth edition, Pharmaceutical Press,
  4. London, UK. Bywater RJ, 1991.
  5. Sulphonamides and Diaminopyrimidines, In: Veterinary Applied Pharmacology and Therapeutics, Eds; Brander GC, Pugh DM, Bywater RJ, Jenkins WL, fifth edition, Baillere Tindall, London, UK, pp: 489-494.
  6. Cockerill FR, Edson RS, 1991. Trimethoprim-sulphamethoxazole. Mayo Clin Proc, 66, 1260-1269.
  7. Falcoz C, Ferry N, Pozet N, Cuisinaud G, Zech PY, Sassard J, 1987. Pharmacokinetics of teicoplanin in renal failure. Antimicrob Agents Chemother, 31, 1255-1262. First MR, 2003.
  8. Renal Function, In: Clinical Chemistry: Theory, Analysis, Correlation, Eds; Kaplan LA, Pesce AJ, Kazmierczak SC, Sixth edition, Mosby, An Affiliate of Elsevier, USA; pp: 477-491.
  9. Foltzer MA, Reese RE, 1987. Trimethoprim-sulphamethoxazole and other sulphonamides. Med Clin North Am, 71, 1177-1194. Hammond KB, 1977. Drugs and children: methods for therapeutics monitoring. Clin Toxicol, 10, 159-183.
  10. Kaneko JJ, Harway JW, Bruss ML, 1997. Clinical Biochemistry of Domestic Animals, Fifth edition, Academic Press,
  11. California, USA. Kayne SB, Jepson MH, 2004.
  12. Veterinary Pharmacy, Pharmaceutical Press,
  13. London, UK. Laemli K, 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
  14. Lee YH, Park KH, Ku YS, 2000. Pharmacokinetic changes of cyclosporine after intravenous and oral administration to rats with uranyl nitrate-induced acute renal failure. Int J Pharm, 194, 221-227.
  15. Maddison JE, Watson AD, 2002.
  16. Antibacterial Drugs, In: Small Animal Clinical Pharmacology, Eds; Maddison JE, Page SW, Church D, Harcourt